MYRIAD GENETICS, INC. Sector revisions Myriad Genetics, Inc.
Equities
MYGN
US62855J1043
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 12.39 USD | -1.04% |
|
-16.45% | -9.63% |
| Jan. 15 | Myriad Genetics, Inc. Presents at 43rd Annual J.P. Morgan Healthcare Conference 2025, Jan-15-2025 03:45 PM | |
| Jan. 15 | Myriad Genetics Expects Higher Q4 Revenue, Provides 2025 Guidance | MT |
Main competitors
| 1m. EPS revision | 1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Divergence of Estimates | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
| 15 | |||||||||
| 15 | |||||||||
| 9 | |||||||||
| 13 | |||||||||
| 13 | |||||||||
| 19 | |||||||||
| 5 | |||||||||
| 4 | |||||||||
| 13 | |||||||||
| - | 2 | ||||||||
| 2 | |||||||||
| - | 2 | ||||||||
| - | - | - | - | ||||||
| 5 | |||||||||
| 1 | |||||||||
| - | 1 | ||||||||
| - | - | ||||||||
| 2 | |||||||||
| Average | 8 | ||||||||
| Weighted average by Cap. | 11 |
- Stock Market
- Equities
- MYGN Stock
- Sector Myriad Genetics, Inc.
- Sector revisions